State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$4.58B |
| 2 |
Marvell Technology
MRVL
|
+$3.71B |
| 3 |
Apple
AAPL
|
+$3.66B |
| 4 |
Microsoft
MSFT
|
+$3.62B |
| 5 |
NVIDIA
NVDA
|
+$3.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$7.17B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.71B |
| 3 |
Micron Technology
MU
|
+$1.62B |
| 4 |
ExxonMobil
XOM
|
+$1.06B |
| 5 |
Chevron
CVX
|
+$873M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.3% |
| 2 | Financials | 12.22% |
| 3 | Industrials | 10.26% |
| 4 | Healthcare | 9.65% |
| 5 | Consumer Discretionary | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Meridian
MRBK
$236M
| $3.73M | ﹤0.01% |
186,047
+53,867
| +41% | +$1.02M |
|
3002
Holley
HLLY
$324M
| $3.7M | ﹤0.01% |
1,450,443
+84,802
| +6% | +$241K |
|
3003
Organogenesis Holdings
ORGO
$181M
| $3.69M | ﹤0.01% |
1,519,955
-5,153
| -0.3% | -$12.6K |
|
|
ASIC
3004
Ategrity Specialty Insurance
ASIC
$1.37B
| $3.68M | ﹤0.01% |
153,268
+17,062
| +13% | +$350K |
|
|
RNA
3005
Atrium Therapeutics
RNA
$168M
| $3.66M | ﹤0.01% |
271,762
+14,676
| +6% | +$192K |
|
3006
James River Group Holdings
JRVR
$181M
| $3.64M | ﹤0.01% |
827,859
+2,184
| +0.3% | +$10.7K |
|
3007
Nkarta
NKTX
$206M
| $3.64M | ﹤0.01% |
1,286,109
+48,635
| +4% | +$137K |
|
3008
Virginia National Bankshares
VABK
$263M
| $3.63M | ﹤0.01% |
81,722
+179
| +0.2% | +$7.6K |
|
3009
Amtech Systems
ASYS
$246M
| $3.6M | ﹤0.01% |
155,849
+98,509
| +172% | +$1.87M |
|
3010
ReNew
RNW
$2.49B
| $3.57M | ﹤0.01% |
570,930
-2,104,056
| -79% | -$11.8M |
|
3011
Lifecore Biomedical
LFCR
$159M
| $3.51M | ﹤0.01% |
668,031
+26,025
| +4% | +$131K |
|
3012
C&F Financial
CFFI
$313M
| $3.5M | ﹤0.01% |
43,533
-512
| -1% | -$38.7K |
|
3013
Tonix Pharmaceuticals
TNXP
$202M
| $3.46M | ﹤0.01% |
271,374
+40,767
| +18% | +$526K |
|
|
NAGE
3014
Niagen Bioscience
NAGE
$238M
| $3.45M | ﹤0.01% |
1,082,752
-1,813
| -0.2% | -$7.36K |
|
3015
Surrozen
SRZN
$203M
| $3.45M | ﹤0.01% |
133,084
+105,358
| +380% | +$2.89M |
|
3016
Crawford & Co Class A
CRD.A
$591M
| $3.44M | ﹤0.01% |
305,269
-844
| -0.3% | -$8.97K |
|
|
ISBA
3017
Isabella Bank
ISBA
$295M
| $3.42M | ﹤0.01% |
86,581
+64,529
| +293% | +$2.76M |
|
3018
BCB Bancorp
BCBP
$152M
| $3.41M | ﹤0.01% |
318,552
+41,508
| +15% | +$424K |
|
3019
Civeo
CVEO
$348M
| $3.41M | ﹤0.01% |
97,485
+88,088
| +937% | +$2.84M |
|
|
IA
3020
Innovative Solutions & Support
IA
$331M
| $3.41M | ﹤0.01% |
189,261
+130,668
| +223% | +$2.53M |
|
3021
Foghorn Therapeutics
FHTX
$247M
| $3.4M | ﹤0.01% |
697,469
+17,682
| +3% | +$78.5K |
|
|
OFRM
3022
Once Upon a Farm PBC
OFRM
$713M
| $3.4M | ﹤0.01% |
165,782
+122,782
| +286% | +$2.01M |
|
3023
JD.com
JD
$36.4B
| $3.39M | ﹤0.01% |
133,188
-16,800
| -11% | -$495K |
|
3024
HUTCHMED
HCM
$2.34B
| $3.37M | ﹤0.01% |
313,611
+8,782
| +3% | +$111K |
|
3025
Precision BioSciences
DTIL
$183M
| $3.36M | ﹤0.01% |
427,325
+354,383
| +486% | +$2.49M |
|
Similar funds
State Street's Q2 2026 Portfolio in Review
As of Q2 2026, State Street held 4,305 positions worth $3.37T, up 16% from $2.9T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.3%. State Street opened 57 new positions and exited 128, leaving the 4,305-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- State Street's largest Q2 2026 buy was Versigent PLC: 2,868,558 shares worth $121M.
- State Street added most to Alphabet (Google) Class A in Q2 2026, an estimated $4.58B increase.
- State Street's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.62B.
- State Street fully exited Honeywell in Q2 2026, selling an estimated $7.17B.
- State Street's ten largest holdings make up 29% of its $3.37T portfolio in Q2 2026.
- State Street opened 57 new positions and closed 128 in Q2 2026.
- State Street's portfolio value rose 16% quarter-over-quarter to $3.37T.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.